Roundtable discussion followed by a Q&A focused on redefining transplant and the role of cell therapy in clinical practice. Participants include:

• Stephan Busque, MD, Stanford University Medical Center
• Dixon Kaufman, MD, PhD, University of Wisconsin School of Medicine and Public Health
• Sanjeev Akkina, MD, Loyola University Medical Center
• Daniel Brennan, MD, Chief Medical Officer, Medeor Therapeutics (Moderator)

Discussion topics:

• Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal
• The Stanford experience – Phase 2 data
• Phase 3 MERCURY tolerance study update
• Integrating cell therapy into clinical practice
• Identifying ideal patient populations for organ transplants

Following the roundtable, Dr. Brennan will provide a company overview and update on future plans.